Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Choice of Hormone Assay to Monitor Feminizing Gender-Affirming Hormone Therapy" [Endocrine Practice 31(12);2025:1521-1529].

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

Medical Care of Transgender Athletes and Policy Implications: ACSM Contemporary Issue Statement - Erratum.

Medicine and science in sports and exercise·2026
Same author

Medical Care of Transgender Athletes and Policy Implications: ACSM Contemporary Issue Statement.

Medicine and science in sports and exercise·2026
Same author

A novel and validated survey explores quality of life outcomes in transgender women following vaginoplasty.

Sexual health·2026
Same author

Preliminary Evidence of Intimate Partner Violence-Related Head Trauma among Transgender and Gender-Diverse Adults.

Violence and gender·2025
Same author

Choice of Hormone Assay to Monitor Feminizing Gender-Affirming Hormone Therapy.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2025

Related Experiment Video

Updated: May 27, 2026

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
04:14

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

Thyroid hormone action on skin.

Joshua D Safer1

  • 1Associate Professor of Medicine and Molecular Medicine; Section of Endocrinology, Diabetes and Nutrition; Boston University School of Medicine; Boston, MA USA.

Dermato-Endocrinology
|November 24, 2011
PubMed
Summary
This summary is machine-generated.

Myxedema, a skin condition linked to thyroid hormone, results from increased glycosaminoglycan deposition. This classic sign of hypothyroidism causes characteristic skin changes, even though it doesn't pit.

Keywords:
cutaneousdermisepidermisskinthyroid hormone

More Related Videos

Studying Chronic Exposure of Mice to Ultraviolet B Radiation
03:20

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

Related Experiment Videos

Last Updated: May 27, 2026

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
04:14

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

Studying Chronic Exposure of Mice to Ultraviolet B Radiation
03:20

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

Area of Science:

  • Endocrinology
  • Dermatology

Background:

  • Thyroid hormone significantly influences skin characteristics.
  • Myxedema is a classic dermatological manifestation associated with thyroid dysfunction.

Purpose of the Study:

  • To describe the skin condition known as myxedema.
  • To explain the pathophysiology of myxedema in relation to thyroid hormone.

Main Methods:

  • Clinical observation of skin changes.
  • Histopathological analysis of skin biopsies (implied).

Main Results:

  • Myxedema involves increased deposition of glycosaminoglycans, such as hyaluronic acid, in the dermis.
  • The affected skin exhibits characteristic changes but does not pit upon pressure.

Conclusions:

  • Generalized myxedema remains a key cutaneous indicator of hypothyroidism.
  • Understanding the dermal changes in myxedema is crucial for diagnosing thyroid disorders.